Understanding thymomas and keyhole surgery for lung cancer

Thymomas are rare tumours originating from the thymus gland, located in the upper chest behind the breastbone. Although often slow-growing and non-invasive, some thymomas can become malignant and spread to surrounding tissues. These tumors are most commonly diagnosed in middle-aged adults and may be discovered incidentally during imaging tests. Symptoms, when present, may include chest pain, persistent cough, or breathing difficulties. In some cases, thymomas are associated with autoimmune conditions, particularly myasthenia gravis.

Treatment for thymomas typically involves surgical removal, often followed by radiation or chemotherapy if the tumor is invasive. A minimally invasive surgical technique known as keyhole surgery, or video-assisted thoracoscopic surgery (VATS), is increasingly being used for both thymomas and early-stage lung cancers. This approach allows surgeons to access the chest cavity through small incisions using a thoracoscope—a tiny camera that guides the procedure.

Keyhole surgery offers several advantages over traditional open-chest surgery. Patients generally experience less pain, a lower risk of complications, and faster recovery times. Hospital stays are shorter, and scarring is minimal. For lung cancer, VATS is commonly used to remove small tumors or affected lobes of the lung (lobectomy), and it has shown comparable oncologic outcomes to open surgery in early-stage cases.

For patients with thymoma or early-stage lung cancer, keyhole surgery represents a promising option with fewer side effects and quicker return to daily life. However, not all patients are candidates for this technique, especially if the tumour is large, invasive, or located in hard-to-reach areas.

A multidisciplinary team—typically including thoracic surgeons, oncologists, and radiologists—will determine the most appropriate treatment plan based on the tumor type, stage, and overall health of the patient. As surgical technology advances, keyhole surgery continues to play an increasingly vital role in thoracic oncology.